aap Implantate AG

Share Issue/Capital Change • Sep 3, 2008

News Details

Ad-hoc | 3 September 2008 09:50

aap closed 5% Capital Increase successfully

aap Implantate AG / Capital Increase

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

aap Implantate AG, a medical technology company listed on the Frankfurt
stock exchange in the Prime Standard segment, has successfully completed
its yesterday announced 5% capital increase. The capital increase was
placed in full by an issue of 1,267,357 shares at a price of EUR 2.18
apiece.

Until the registration of the implementation of the capital increase and
the listing of the new shares – expected to be effected end of September
2008 – a major shareholder of the company made own shares available by a
temporary securities loan for the investors supply.

Subject to the recording of the capital increase in the commercial register
the company’s capital will increase by EUR 1,267,357 from the present EUR
25,347,156 to EUR 26,614,513, divided into the same number of registered
shares. From the capital increase the company receives more than EUR 2.7,
intended to serve the purpose of funding further growth.

Contact:
Please address any queries to:
aap Implantate AG; Nanette Hüdepohl; Head of Corporate Communications &
Legal Affairs; Lorenzweg 5; D-12099 Berlin
Tel.: ++49/30/750 19 – 133; Fax.: ++49/30/750 19 – 290; n.huedepohl@aap.de

03.09.2008 Financial News transmitted by DGAP

Language: English
Issuer: aap Implantate AG
Lorenzweg 5
12099 Berlin
Deutschland
Phone: +49 (0) 30 75 01 90
Fax: +49 (0) 30 75 01 91 11
E-mail: aap@aap.de
Internet: www.aap.de
ISIN: DE0005066609
WKN: 506660
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Hannover, Düsseldorf, Hamburg, München, Stuttgart

End of News DGAP News-Service

---